Is ELV or NVO cheaper?

On trailing earnings, NVO is cheaper: ELV trades at a 16.64 P/E and NVO at 10.18.

Which has grown faster, ELV or NVO?

Over the past five years, NVO grew revenue faster — ELV at a 9.97% CAGR versus NVO at 20.73%.

Does ELV or NVO pay a bigger dividend?

ELV yields 1.75% and NVO yields 4.14% based on trailing dividends and the latest price.

Is ELV or NVO more profitable?

NVO runs the higher net margin — ELV at 2.62% versus NVO at 37.14%.

Which has been the better investment, ELV or NVO?

Over the past 10-year, ELV delivered the higher annualized total return — ELV at 13.01% versus NVO at 7.78%. Past performance doesn't predict future results.

Elevance Health Inc. (ELV) vs Novo Nordisk A/S (NVO)

NVO leads on 12 of 16 compared metrics.

A side-by-side comparison of Elevance Health Inc. and Novo Nordisk A/S across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 18, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — ELV vs NVO

growth of $100 · last 25y

ELV +1813.3%NVO +2066.7%NVO compounded faster

ELV NVO

ELV vs NVO: by the numbers

•NVO is the larger company ($191.59B vs $84.97B market cap).
•NVO trades at the lower earnings multiple (10.18 vs 16.64 P/E).
•NVO converts more revenue to profit (37.14% vs 2.62% net margin).
•NVO grew revenue faster over the past five years (20.73% vs 9.97% CAGR).
•NVO pays the higher dividend yield (4.14% vs 1.75%).

Which is better, ELV or NVO?

Metric tally: ELV 4 · NVO 12

It depends on what you're optimizing for:

ValueNVO(lower P/E)

GrowthNVO(faster 5Y revenue CAGR)

IncomeNVO(higher dividend yield)

QualityNVO(higher ROIC)

Metrics side by side

Valuation

Metric	ELV	NVO
P/E ratio	16.64	10.18●
Forward P/E	13.38	—
P/S ratio	0.43●	3.78
P/B ratio	1.96●	6.18
PEG ratio	2.50●	8.17
EV / EBITDA	12.16	7.34●
FCF yield	7.48%●	2.50%

Profitability

Metric	ELV	NVO
Gross margin	23.16%	81.83%●
Operating margin	3.81%	45.21%●
Net margin	2.62%	37.14%●
ROE	11.94%	60.74%●
ROIC	6.65%	29.53%●

Dividends

Metric	ELV	NVO
Dividend yield	1.75%	4.14%●
Payout ratio	27.24%	49.80%

Growth (annualized)

Metric	ELV	NVO
Revenue CAGR (5Y)	9.97%	20.73%●
EPS CAGR (5Y)	6.67%	19.59%●
FCF CAGR (5Y)	-7.76%	-5.86%●
Total return CAGR (5Y)	2.16%	3.08%●

Frequently asked

Which is better, ELV or NVO?: It depends on your goal. value: NVO (lower P/E); growth: NVO (faster 5Y revenue CAGR); income: NVO (higher dividend yield); quality: NVO (higher ROIC). Across all compared metrics, NVO leads 12 to 4.
Is ELV or NVO cheaper?: On trailing earnings, NVO is cheaper: ELV trades at a 16.64 P/E and NVO at 10.18.
Which has grown faster, ELV or NVO?: Over the past five years, NVO grew revenue faster — ELV at a 9.97% CAGR versus NVO at 20.73%.
Does ELV or NVO pay a bigger dividend?: ELV yields 1.75% and NVO yields 4.14% based on trailing dividends and the latest price.
Is ELV or NVO more profitable?: NVO runs the higher net margin — ELV at 2.62% versus NVO at 37.14%.
Which has been the better investment, ELV or NVO?: Over the past 10-year, ELV delivered the higher annualized total return — ELV at 13.01% versus NVO at 7.78%. Past performance doesn't predict future results.

Go deeper

Full ELV analysis Full NVO analysis Interactive comparison tool

Dig into the metrics

Elevance Health P/E ratio Novo Nordisk A/S P/E ratio Elevance Health dividend yield Novo Nordisk A/S dividend yield Elevance Health ROE Novo Nordisk A/S ROE Elevance Health operating margin Novo Nordisk A/S operating margin Elevance Health revenue growth Novo Nordisk A/S revenue growth Elevance Health free cash flow Novo Nordisk A/S free cash flow

Elevance Health & Novo Nordisk A/S appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 18, 2026.